Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients
Autor: | Aymeric Auger, Laura Santambrogio, Patricia Corthésy, Davide Demurtas, Emanuela Romano, Melody A. Swartz, Lambert Potin, Maurice Matter, Cristina C. Clement, Romain Hamelin, Alexandre Harari, Daniel E. Speiser, Natacha Bordry, Lea Maillat, Maria A. S. Broggi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Proteomics Skin Neoplasms medicine.medical_treatment pathways Exosomes Mice 0302 clinical medicine Immunology and Allergy Melanoma Research Articles S100 Proteins Extracellular vesicle Exudates and Transudates proteomic analysis invasion macrophages Lymphatic system 030220 oncology & carcinogenesis Lymphatic Metastasis Cytokines Lymph medicine.symptom Exudate Immunology Article 03 medical and health sciences Extracellular Vesicles Animals Biomarkers Tumor/analysis Cell Line Tumor Cytokines/analysis Exosomes/metabolism Extracellular Vesicles/metabolism Exudates and Transudates/metabolism Humans Lymph/metabolism Lymph Node Excision Lymphatic Vessels/metabolism Melanoma/blood Melanoma/pathology Melanoma/secondary Melanoma/surgery Mice Inbred C57BL MicroRNAs/analysis Proteomics/methods S100 Proteins/analysis Skin Neoplasms/blood Skin Neoplasms/pathology Skin Neoplasms/secondary Skin Neoplasms/surgery medicine Biomarkers Tumor Lymphatic Vessels business.industry Cancer medicine.disease cancer progression proteins MicroRNAs 030104 developmental biology Cancer research peptides cells Lymphadenectomy Cancer biomarkers business |
Zdroj: | The Journal of Experimental Medicine The Journal of experimental medicine, vol. 216, no. 5, pp. 1091-1107 |
ISSN: | 1540-9538 0022-1007 |
Popis: | Identifying cancer biomarkers is of great interest for patient prognosis and monitoring. However, tumor-associated factors are diluted in blood and challenging to detect. Broggi et al. show that lymphatic exudate, accessible at the time of lymphadenectomy, is highly enriched in tumor-associated factors and therefore a promising source for biomarker discovery. Liquid biopsies allow monitoring of cancer progression and detection of relapse, but reliable biomarkers in melanoma are lacking. Because secreted factors preferentially drain to lymphatic vessels before dilution in the blood, we hypothesized that lymph should be vastly enriched in cancer biomarkers. We characterized postoperative lymphatic exudate and plasma of metastatic melanoma patients after lymphadenectomy and found a dramatic enrichment in lymphatic exudate of tumor-derived factors and especially extracellular vesicles containing melanoma-associated proteins and miRNAs, with unique protein signatures reflecting early versus advanced metastatic spread. Furthermore, lymphatic exudate was enriched in memory T cells, including tumor-reactive CD137+ and stem cell–like types. In mice, lymph vessels were the major route of extracellular vesicle transport from tumors to the systemic circulation. We suggest that lymphatic exudate provides a rich source of tumor-derived factors for enabling the discovery of novel biomarkers that may reflect disease stage and therapeutic response. Graphical Abstract |
Databáze: | OpenAIRE |
Externí odkaz: |